Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Haematologica|May 25, 2023
Patient-reported treatment response in chronic graft-versus-host diseaseAnnie Im, Iskra Pusic, Lynn Onstad, et al.
Blood Advances|September 14, 2021
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD ConsortiumZachariah DeFilipp, Amin M Alousi, Joseph A Pidala, et al.
Blood|July 1, 2022
KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trialMichael A Pulsipher, Kwang W Ahn, Nancy J Bunin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationCraig J Galbán, Jennifer L Boes, Maria Bule, et al.
Blood Advances|September 17, 2021
Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survivalJoseph Pidala, Lynn Onstad, Paul J Martin, et al.
Transplantation and Cellular Therapy|July 30, 2023
Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National RegistryNancy Gillis, Eric Padron, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2010
Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host diseasePaul J Martin, Barry E Storer, Paul A Carpenter, et al.
Bone Marrow Transplantation|October 17, 2024
Incidence of bacterial blood stream infections in patients with acute GVHDWhitney Wallis, Alison M Gulbis, Tao Wang, et al.
Blood|October 4, 2008
A biomarker panel for acute graft-versus-host diseaseSophie Paczesny, Oleg I Krijanovski, Thomas M Braun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective SeriesAttaphol Pawarode, Shin Mineishi, Pavan Reddy, et al.
Pageof 10